Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa

INTRODUCTION: Some observational data suggest that the progestogen injectable contraceptive depot medroxyprogesterone acetate (DMPA) may increase a woman’s risk of HIV acquisition but a randomized clinical trial did not find a statistically significant increase in HIV risk for women using DMPA compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jennifer A, Beacroft, Leo, Abdullah, Fareed, Buthelezi, Buyile, Makua, Manala, Morroni, Chelsea, Ramjee, Gita, Velasquez, Claudia, Hallett, Timothy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543057/
https://www.ncbi.nlm.nih.gov/pubmed/33030312
http://dx.doi.org/10.1002/jia2.25620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543057/
https://www.ncbi.nlm.nih.gov/pubmed/33030312
http://dx.doi.org/10.1002/jia2.25620

Ejemplares similares